Improved efficacy with amodiaquine instead of chloroquine in sulfadoxine/pyrimethamine combination treatment of falciparum malaria in Uganda: Experience with fixed-dose formulation

Acta Tropica

Volumn 100, Issue 1-2, 2006, Pages 142-150

  Obua, C ^a,b   Gustafsson, L L ^b   Aguttu, C ^a   Anokbonggo, W W ^a   Ogwal Okeng, J W ^a   Chiria, J ^c   Hellgren, U ^b  

^a MAKERERE UNIVERSITY   (Uganda)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c ABC Statistical Services   (Uganda)

Author keywords

Amodiaquine; Chloroquine; Clinical trial; Falciparum malaria; Fixed dose formulation; Sulfadoxine pyrimethamine

Indexed keywords

AMODIAQUINE; CHLOROQUINE; CHLOROQUINE PLUS FANSIDAR; FANSIDAR; HOMAPAK; PARACETAMOL; QUININE;

ANTIBIOTICS; CHILD HEALTH; DISEASE TREATMENT; DRUG PRESCRIBING; IMMUNOASSAY; MALARIA;

ABDOMINAL PAIN; ANEMIA; ANOREXIA; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; DIARRHEA; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EYE SWELLING; FEMALE; FEVER; FOLLOW UP; GAMETOCYTE; GROUPS BY AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PARASITOLOGY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; SINGLE BLIND PROCEDURE; SORE THROAT; STATISTICAL SIGNIFICANCE; TABLET FORMULATION; TREATMENT OUTCOME; TREATMENT RESPONSE; URBAN AREA; WEAKNESS; WORLD HEALTH ORGANIZATION;

AMODIAQUINE; ANIMALS; ANTIMALARIALS; CHILD, PRESCHOOL; CHLOROQUINE; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; HUMANS; INFANT; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; SULFADOXINE; TREATMENT OUTCOME; UGANDA;

AFRICA; BUSOGA; EAST AFRICA; JINJA; SUB-SAHARAN AFRICA; UGANDA;

PLASMODIUM FALCIPARUM;

EID: 33751546313     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2006.10.007     Document Type: Article

References (40)

1. Bakyaita N., Dorsey G., Yeka A., Banek K., Staedke S.G., Kamya M.R., Talisuna A., Kironde F., Nsobya S., Kilian A., Reingold A., Rosenthal P.J., and Wabwire-Mangen F. Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda. Am. J. Trop. Med. Hyg. 72 (2005) 573-580
2. Basco L.K., and Ringwald P. Molecular epidemiology of malaria in Yaounde, Cameroon. VII. Analaysis of recrudescence and reinfection in patients with uncomplicated falciparum malaria. Am. J. Trop. Med. Hyg. 63 (2000) 215-221
3. Basco L.K., and Ringwald P. Molecular epidemiology of malaria in Yaounde, Cameroon. VIII. Multiple Plasmodium falciparum infection in symptomatic patients. Am. J. Trop. Med. Hyg. 65 (2001) 798-803
4. Bloland P.B. A contrarian view of malaria therapy policy in Africa. Am. J. Trop. Med. Hyg. 68 (2003) 125-126
5. Cattamanchi A., Kyabayinze D., Hubbard A., Rosenthal P.J., and Dorsey G. Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp. Am. J. Trop. Med. Hyg. 68 (2003) 133-139
6. D'Alessandro U., Talisuna A., and Boelaert M. Should artemisinin-based combination treatment be used in the home-based management of malaria?. Trop. Med. Int. Health 10 (2005) 1-2
7. Dorsey G., Njama D., Kamya M.R., Cattamanchi A., Kyabayinze D., Staedke S.G., Gasasira A., and Rosenthal P.J. Sulfadoxine/pyrimetamin alone and with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial. Lancet 360 (2002) 2031-2038
8. East African Network for Monitoring Antimalrial Treatment (EANMAT). The efficacy of antimalarial monotherapies, sulfadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy. Trop. Med. Int. Health 8 (2003) 860-867
9. Farnert A., Snounou G., Rooth I., and Bjorkman A. Daily dynamics of Plasmodium falciparum subpopulations in asymptomatic children in a holoendemic area. Am. J. Trop. Med. Hyg. 56 (1997) 538-547
10. Gasasira A.F., Dorsey G., Nzarubara B., Staedke S.G., Nassali A., Rosenthal P.J., and Kamya M.R. Comparative efficacy of aminoquinoline-antifolate combination therapy for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. Am. J. Trop. Med. Hyg. 68 (2003) 127-132
11. GlobalHealthReporting.org, 2005. Malaria: WHO announces shortage of "most effective" malaria drug through March 2005 (posted March 16, 2005) http://www.kaisernetwork.org/daily_reports/rep_index.cfm (accessed August 29, 2005).
12. Hamer D.H., MacLeod W.B., Addo-Yobo E., Duggan C.P., Estrella B., Fawzi W.W., Konde-Lule J.K., Mwanakasale V., Premji Z.G., Sempertegui F., Ssengooba F.P., Yeboah-Antwi K., and Simon J.L. Age, temperature, and parasitaemia predict chloroquine treatment failure and anaemia in children with uncomplicated Plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 97 (2003) 422-428
13. Hatton C.S., Peto T.E., Bunch C., Pasvol G., Russell S.J., Singer C.R., Edwards G., and Winstanley P. Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet 1 (1986) 411-414
14. Huitfeldt B. Statistical aspects of clinical trials of antibiotics in acute infections. Rev. Infect. Dis. 8 (1986) S350-S357
15. Kamya M.R., Dorsey G., Gasasira A., Ndeezi G., Babirye J.N., Staedke S.G., and Rosenthal P.J. The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. Trans. R. Soc. Trop. Med. Hyg. 95 (2001) 50-55
16. Kilian A.H., Tindyebwa D., Gulck T., Byamukama W., Rubaale T., Kabagambe G., and Korte R. Attitude of women in western Uganda towards pre-packed, unit-dosed malaria treatment for children. Trop. Med. Int. Health 8 (2003) 431-438
17. Martensson A., Stromberg J., Sisowath C., Msellem M.I., Gil J.P., Montgomery S.M., Olliaro P., Ali A.S., and Bjorkman A. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Clin. Infect. Dis. 41 (2005) 1079-1086
18. Mockenhaupt F.P., Ehrhardt S., Eggelte T.A., Markert M., Anemana S., Otchwemah R., and Bienzle U. Plasmodium falciparum multiplicity correlates with anaemia in symptomatic malaria. Trop. Med. Int. Health 8 (2003) 857-859
19. Mockenhaupt F.P., Ehrhardt S., Dzisi S.Y., Teun Bousema J., Wassilew N., Schreiber J., Anemana S.D., Cramer J.P., Otchwemah R.N., Sauerwein R.W., Eggelte T.A., and Bienzle U. A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria. Trop. Med. Int. Health 10 (2005) 512-520
20. Ministry of Health (MoH), Uganda. Implementation Guidelines for the Home Based Management of Fever Strategy. 1st ed. (2002), MoH, The Republic of Uganda
21. Ndyomugyenyi R., Magnussen P., and Clarke S. The efficacy of chloroquine, sulfadoxine-pyrimethamine and a combination of both for the treatment of uncomplicated Plasmodium falciparum malaria in an area of low transmission in western Uganda. Trop. Med. Int. Health 9 (2004) 47-52
22. Neftel K.A., Woodtly W., Schmid M., Frick P.G., and Fehr J. Amodiaquine induced agranulocytosis and liver damage. Br. Med. J. 292 (1986) 721-723
23. Nsungwa-Sabiiti J., Tomson G., Pariyo G., Ogwal-Okeng J., and Peterson S. Community effectiveness of malaria treatment-a long way from Abuja targets. Ann. Trop. Paediatr. 25 (2005) 91-100
24. Oduro A.R., Anyorigiya T., Hodgson A., Ansah P., Anto F., Ansah N.A., Atuguba F., Mumuni G., and Amankwa J. A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana. Trop. Med. Int. Health 10 (2005) 279-284
25. Olliaro P., Nevill C., LeBras J., Ringwald P., Mussano P., Garner P., and Brasseur P. Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet 348 (1996) 1196-1201
26. Sowunmi A., Fehintola F.A., Adedeji A.A., Gbotosho G.O., Tambo E., Fateye B.A., Happi T.C., and Oduola A.M. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children. Trop. Med. Int. Health 10 (2005) 1161-1170
27. Staedke S.G., Kamya M.R., Dorsey G., Gasasira A., Ndeezi G., Charlebois E.D., and Rosenthal P.J. Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala Uganda: a randomised trial. Lancet 358 (2001) 368-374
28. Staedke S.G., Mpimbaza A., Kamya M.R., Nzarubara B.K., Dorsey G., and Rosenthal P. Combination treatments for uncomplicated falciparum malaria in Kampla, Uganda: randomised clinical trial. Lancet 364 (2004) 1950-1957
29. Sowunmi A., and Fateye B.A. Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs. Trop. Med. Int. Health 8 (2003) 783-792
30. Talisuna A.O., Nalunkuma-Kazibwe A., Bakyaita N., Langi P., Mutabingwa T.K., Watkins W.W., Van Marck E., D'Alessandro U., and Egwang T.G. Efficacy of sulfadoxine-pyrimethamine alone or combined with amodiaquine or chloroquine for the treatment of uncomplicated falciparum malaria in Ugandan children. Trop. Med. Int. Health 9 (2004) 222-229
31. Tjitra1 E., Suprianto S., and Anstey N.M. Higher gametocyte prevalence following failure of treatment of Plasmodium falciparum malaria with sulfadoxine-pyrimethamine and the combination of chloroquine plus sulfadoxine-pyrimethamine: implications for progression of anti-folate resistance. Trans. R. Soc. Trop. Med. Hyg. 96 (2002) 434-437
32. Uganda Bureau of Statistics, UBOS. Uganda Demographic and Health Survey 2000-2001 (2001), UBOS, Entebbe, Uganda pp 8-10
33. World Health Organization, 1990. Practical chemotherapy of malaria: report of a WHO scientific group. Technical Report Series WHO 805, Geneva.
34. World Health Organisation, 1993. 19th Expert Committee on Malaria. Report, WHO, Geneva.
35. World Health Organization, 1997. Management of Uncomplicated Malaria and the Use of Antimalarial Drug for Protecting Travellers. Report. WHO/MAL/96.1075 Geneva.
36. World Health Organization, 2001. Antimalarial drug combination therapy. Report of a WHO Technical Consultation. Geneva http://www.who.int/cmc_upload/0/000/015/082/use_of_antimalarials2.pdf (accessed 19.8.2005).
37. World Health Organization, 2003. Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Malaria. WHO Protocol http://www.emro.who.int/rbm/publications/protocolwho.pdf (accessed 24.6.2004).
38. World Health Organization, 2004. WHO Information note on artemether/lumefantrine (Coartem) availability: update on expected supply situation for 2005 http://www.hcpartnership.org/Topics/malaria/CoartemShortageUpdate.doc (accessed 29.8.2005).
39. World Health Organization, 2005. World malaria Report. WHO, Geneva http://www.rbm.who.int/wmr2005/pdf/adv_e.pdf (accessed 19.8.2005).
40. Yeka A., Banek K., Bakyaita N., Staedke S.G., Kamya M.R., Talisuna A., Kironde F., Nsobya S.L., Kilian A., Slater M., Reingold A., Rosenthal P.J., Wabwire-Mangen F., and Dorsey G. Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. PloS Med 2 (2005) e190